IL4R and Alzheimer disease: Listed drugs for AD (dupilumab, an anti-IL-4Rα monoclonal antibody, and JAK inhibitors) are aimed at single targets; contrastingly, HLJDT might play an anti-pruritus role in a multitarget and multiway manner.